Analysis and Commentary Guest User 7/10/20 Analysis and Commentary Guest User 7/10/20 CBER Director on COVID-19 and Vaccine Development Read More Advocacy at a Glance Guest User 7/10/20 Advocacy at a Glance Guest User 7/10/20 House Appropriations Committee Votes for $41 Million Increase for FDA in FY 21 Read More Analysis and Commentary Guest User 6/26/20 Analysis and Commentary Guest User 6/26/20 FDA Is Its People … and They Need Our Support (Redux) Read More Advocacy at a Glance Guest User 6/26/20 Advocacy at a Glance Guest User 6/26/20 Upcoming Webinar with CBER Director Peter Marks, MD Read More Analysis and Commentary Guest User 6/19/20 Analysis and Commentary Guest User 6/19/20 How Well Is This Year's Appropriation Process Working? Read More Advocacy at a Glance Guest User 6/19/20 Advocacy at a Glance Guest User 6/19/20 Upcoming Webinar with CBER Director Peter Marks, MD Read More Analysis and Commentary Guest User 6/12/20 Analysis and Commentary Guest User 6/12/20 "I Believe in FDA Exceptionalism and You Should Too" Read More Advocacy at a Glance Guest User 6/12/20 Advocacy at a Glance Guest User 6/12/20 House and Senate Set Schedule for FY 21 Appropriations Mark-Ups Read More Analysis and Commentary Guest User 6/5/20 Analysis and Commentary Guest User 6/5/20 Pandemic Actions Taken ... and Lessons Learned Read More Advocacy at a Glance Guest User 6/5/20 Advocacy at a Glance Guest User 6/5/20 Commissioner Hahn’s Address to the Alliance Gains Wide Attention Read More Advocacy at a Glance Guest User 5/22/20 Advocacy at a Glance Guest User 5/22/20 Hurry Up and Slow Down (Once Again) Read More Advocacy at a Glance Guest User 5/22/20 Advocacy at a Glance Guest User 5/22/20 Procedural Path Cleared for House Mark-up Appropriations; Impediments Remain Read More Analysis and Commentary Guest User 5/15/20 Analysis and Commentary Guest User 5/15/20 How H.R. 6800 Might Impact the FDA Read More Advocacy at a Glance Guest User 5/15/20 Advocacy at a Glance Guest User 5/15/20 Virtual Mark-ups: Prerequisite for Movement of Appropriations Bills Read More Analysis and Commentary Guest User 5/8/20 Analysis and Commentary Guest User 5/8/20 The Frieden Health Defense Funding Proposition Read More Advocacy at a Glance Guest User 5/8/20 Advocacy at a Glance Guest User 5/8/20 House and Senate Appropriations Committees Still Committed, Off to a Slow Start Read More Analysis and Commentary Guest User 5/1/20 Analysis and Commentary Guest User 5/1/20 No Need for a Crystal Ball in Some Scenarios Read More Advocacy at a Glance Guest User 5/1/20 Advocacy at a Glance Guest User 5/1/20 Senate Returns May 4; Appropriations Activities Planned and Rules for Remote Voting Are Prominent Read More Analysis and Commentary Guest User 4/24/20 Analysis and Commentary Guest User 4/24/20 How Can Congress Agree to Appropriations for FY 21? Read More Advocacy at a Glance Guest User 4/24/20 Advocacy at a Glance Guest User 4/24/20 Appropriations Committees Still Have No Schedule; House Rules Do Not Permit Remote Mark-ups Read More Newer Posts Older Posts
Analysis and Commentary Guest User 7/10/20 Analysis and Commentary Guest User 7/10/20 CBER Director on COVID-19 and Vaccine Development Read More
Advocacy at a Glance Guest User 7/10/20 Advocacy at a Glance Guest User 7/10/20 House Appropriations Committee Votes for $41 Million Increase for FDA in FY 21 Read More
Analysis and Commentary Guest User 6/26/20 Analysis and Commentary Guest User 6/26/20 FDA Is Its People … and They Need Our Support (Redux) Read More
Advocacy at a Glance Guest User 6/26/20 Advocacy at a Glance Guest User 6/26/20 Upcoming Webinar with CBER Director Peter Marks, MD Read More
Analysis and Commentary Guest User 6/19/20 Analysis and Commentary Guest User 6/19/20 How Well Is This Year's Appropriation Process Working? Read More
Advocacy at a Glance Guest User 6/19/20 Advocacy at a Glance Guest User 6/19/20 Upcoming Webinar with CBER Director Peter Marks, MD Read More
Analysis and Commentary Guest User 6/12/20 Analysis and Commentary Guest User 6/12/20 "I Believe in FDA Exceptionalism and You Should Too" Read More
Advocacy at a Glance Guest User 6/12/20 Advocacy at a Glance Guest User 6/12/20 House and Senate Set Schedule for FY 21 Appropriations Mark-Ups Read More
Analysis and Commentary Guest User 6/5/20 Analysis and Commentary Guest User 6/5/20 Pandemic Actions Taken ... and Lessons Learned Read More
Advocacy at a Glance Guest User 6/5/20 Advocacy at a Glance Guest User 6/5/20 Commissioner Hahn’s Address to the Alliance Gains Wide Attention Read More
Advocacy at a Glance Guest User 5/22/20 Advocacy at a Glance Guest User 5/22/20 Hurry Up and Slow Down (Once Again) Read More
Advocacy at a Glance Guest User 5/22/20 Advocacy at a Glance Guest User 5/22/20 Procedural Path Cleared for House Mark-up Appropriations; Impediments Remain Read More
Analysis and Commentary Guest User 5/15/20 Analysis and Commentary Guest User 5/15/20 How H.R. 6800 Might Impact the FDA Read More
Advocacy at a Glance Guest User 5/15/20 Advocacy at a Glance Guest User 5/15/20 Virtual Mark-ups: Prerequisite for Movement of Appropriations Bills Read More
Analysis and Commentary Guest User 5/8/20 Analysis and Commentary Guest User 5/8/20 The Frieden Health Defense Funding Proposition Read More
Advocacy at a Glance Guest User 5/8/20 Advocacy at a Glance Guest User 5/8/20 House and Senate Appropriations Committees Still Committed, Off to a Slow Start Read More
Analysis and Commentary Guest User 5/1/20 Analysis and Commentary Guest User 5/1/20 No Need for a Crystal Ball in Some Scenarios Read More
Advocacy at a Glance Guest User 5/1/20 Advocacy at a Glance Guest User 5/1/20 Senate Returns May 4; Appropriations Activities Planned and Rules for Remote Voting Are Prominent Read More
Analysis and Commentary Guest User 4/24/20 Analysis and Commentary Guest User 4/24/20 How Can Congress Agree to Appropriations for FY 21? Read More
Advocacy at a Glance Guest User 4/24/20 Advocacy at a Glance Guest User 4/24/20 Appropriations Committees Still Have No Schedule; House Rules Do Not Permit Remote Mark-ups Read More
